The Longest Living Patient Supported With Left Ventricular Assist Device (14 Years).

IF 3.1 3区医学 Q2 ENGINEERING, BIOMEDICAL

ASAIO Journal Pub Date : 2024-10-01 Epub Date: 2024-09-26 DOI:10.1097/MAT.0000000000002184

Ann Hallberg Kristensen, Peter Svenarud, Lars H Lund, Emil Najjar

引用次数: 0

Abstract

Left ventricular assist devices (LVADs) improve survival and reduce symptoms in patients with advanced heart failure; however, the longer-term durability of LVADs remains uncertain especially with older-generation devices. In this case report, we describe the clinical course of a patient who has been successfully treated with the same HeartMate II LVAD for 14 years, the longest published and still ongoing LVAD support with the same originally implanted device.

查看原文本刊更多论文

使用左心室辅助装置支持的最长寿患者（14 岁）。

左心室辅助装置（LVAD）可提高晚期心力衰竭患者的生存率并减轻症状；然而，左心室辅助装置的长期耐用性仍不确定，尤其是老一代装置。在本病例报告中，我们描述了一名患者的临床病程，该患者使用同一台 HeartMate II LVAD 已成功治疗了 14 年，是目前已发表的使用同一台最初植入的设备进行 LVAD 支持时间最长的患者。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

ASAIO Journal 医学-工程：生物医学

CiteScore

6.60

自引率

7.10%

发文量

651

审稿时长

4-8 weeks

期刊介绍： ASAIO Journal is in the forefront of artificial organ research and development. On the cutting edge of innovative technology, it features peer-reviewed articles of the highest quality that describe research, development, the most recent advances in the design of artificial organ devices and findings from initial testing. Bimonthly, the ASAIO Journal features state-of-the-art investigations, laboratory and clinical trials, and discussions and opinions from experts around the world. The official publication of the American Society for Artificial Internal Organs.